Moreover, BCLC stage B or C (HR = 3.412) and IFN-γ producing NK cell proportion at 1 month after treatment < 45% (HR = 6.934) independently predicted an increased risk of HCC recurrence (all P < 0.05). This evidence concerns the gene IFNG and hepatocellular carcinoma.